Navigation Links
Test of bacteria toxin delivery system could pave way for new antibiotic drugs
Date:6/16/2008

Jerusalem, June 16, 2008 Researchers at the Hebrew University of Jerusalem have achieved a breakthrough in monitoring the toxin-delivery system of highly pathogenic bacteria an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs.

Most bacteria are harmless and do not cause infections. Some, however, are pathogenic and are equipped with special accessories that are used to deliver toxins (also termed "effectors") into the cells of the infected person.

Numerous bacteria that cause disease, ranging from food poisoning to life threatening infection, employ a syringe-like nano-organelle (a specialized part of a cell having a specific function) that is used to inject toxic effectors into attacked host cells. This process is termed a type III secretion system (TTSS). Among these pathogens are Salmonella; the cause of typhoid fever, Yersinia; and enteropathogenic (intestinal) E. coli, which is responsible for the death of up to one million infants per year, mostly in developing countries.

The bacterial syringe employed by these bacteria is an excellent potential target for drugs (not yet available) to combat these diseases. In order to develop such drugs, however, a better understanding of the syringe functions is needed, requiring development of better methods for measuring the syringe activity.

The Hebrew University researchers Ilan Rosenshine, the Etta Rosensohn Professor of Bacteriology at the Hebrew University Faculty of Medicine, and his associates -- Erez Mills, Kobi Baruch, Xavier Charpentier and Simi Kobi -- have designed a new, real-time test that allows monitoring the syringe activity. Using this test, they have discovered new properties of this system, which might be used to develop drugs that will inhibit the syringe activity and thereby prevent disease and infection by these dangerous pathogens

Their achievement was described in a recent article
'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Shuttle brings space-grown strep bacteria back for study
2. The worlds oldest bacteria
3. Bacteria from sponges make new pharmaceuticals
4. Boston University biomedical engineers find chink in bacterias armor
5. University of Leicester scientists discover technique to help friendly bacteria
6. Spaceflight shown to alter ability of bacteria to cause disease
7. A tiny pinch from a z-ring helps bacteria cells divide
8. Legionnaires bacterial proteins work together to survive
9. Scripps research team blocks bacterial communication system to prevent deadly staph infections
10. NSF awards Stevens team $1 million for research on smart, bacteria-repellent nanohydrogels
11. Chemical compound present in detergents produce bacteria alterations in agricultural soils
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Test of bacteria toxin delivery system could pave way for new antibiotic drugs
Test of bacteria toxin delivery system could pave way for new antibiotic drugs
(Date:3/21/2010)... release is available in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2010-03/asu-etb031810.php,">Chinese . ... debate in the U.S. Congress to ban the ... growing global environmental problem even worse, say authors ... Science and Technology appearing online today. , ... trade bans can prevent "backyard recycling" of electronics ...
(Date:3/21/2010)... Technology (Caltech)-led team of researchers and clinicians has ... as an experimental therapeutic and injected directly into ... small interfering RNAs (siRNAs), and turn off an ... RNA interference (RNAi). Moreover, the team provided the ... infused into the bloodstream, can make its way ...
(Date:3/18/2010)... for twenty years, fertilizing millions of eggs with sperm stored ... researchers who have studied ants at the Smithsonian Tropical Research ... and bee species in which queens have multiple mates, a ... over the other males, sperm. However, once sperm has been ...
Breaking Biology News(10 mins):E-waste trade ban won't end environmental threat 2Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 2Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 3Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 4Females shut down male-male sperm competition in leafcutter ants 2Nearly 100 HIV AIDS Drugs and Vaccines in Development Pipeline 6904 1Nearly 100 HIV AIDS Drugs and Vaccines in Development Pipeline 6904 2Alcohol consumption may increase breast cancer recurrence risk 63050 1Alcohol consumption may increase breast cancer recurrence risk 63050 2Synthetic protein mimics structure function of metalloprotein in nature 11087 1Synthetic protein mimics structure function of metalloprotein in nature 11087 2
... a naturally occurring toxin called Glycoalkaloids (GA) and pose a ... in the latest online issue of SCI,s Journal of ... the good news is that cutting away the ,green, affected ... reduce the risk. , The paper also suggests that ...
... Massachusetts General Hospital (MGH) investigators has developed a powerful ... robust method for generating synthetic enzymes that can target ... In the July 25 issue of Molecular Cell, ... to engineer customized zinc-finger nucleases (ZFNs), which can be ...
... inside the Arctic Circle, scientists have found black smoker vents ... of five vents one towering nearly four stories in ... Dissolved sulfide minerals that solidify when vent water hits the ... accumulated around the vent field in what is one of ...
Other Biology News:Consortium develops new method enabling routine targeted gene modification 2Scientists break record by finding northernmost hydrothermal vent field 2Scientists break record by finding northernmost hydrothermal vent field 3
(Date:3/18/2010)... Regenerative ... ... Cell Therapy Group is pleased to formally announce the addition of three new team ... Director, Stem Cell & Medical Device Business, and John E. Hambor, PhD as Director, ...
(Date:3/17/2010)... that Nano Research , an English-language journal jointly published ... the Science Citation Index-Expanded (SCI-E). The academic journal, founded ... Volume 1, Issue 1. Nano Research is part ... than 90 journals. , Nano Research is an ...
(Date:3/17/2010)... ,,, BALTIMORE , March 17 Champions Biotechnology, Inc. (OTC Bulletin Board: ... to enhance the value of oncology drugs, today announced its financial results for the third ... available in the Company,s Form 10-Q at www.championsbiotechnology.com . , ... ...
(Date:3/17/2010)... /PRNewswire-FirstCall/ - Æterna Zentaris Inc. ( AEZS, TSX: AEZ) (the "Company"), a late-stage ... and full year 2009 financial and operating results before market open on ... webcast to discuss these results later that same day at 10:00 a.m., ... ...
Breaking Biology Technology:Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine 2Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine 3Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine 4China's first open-access journal Nano Research listed in Science Citation Index 2Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 5Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 6Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 7Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results 8Æterna Zentaris to Announce Fourth Quarter Full Year 2009 Financial and Operating Results on March 24, 2010 2
... FRANCISCO, Calif., June 16 Anesiva,Inc. (Nasdaq: ANSV ... as,president, chief executive officer and a member of the ... succeeds John P. McLaughlin,who resigned as chief executive officer ... interests, while remaining a consultant to the,company., "Michael ...
... June 16 ,EnzySurge Ltd. (EnzySurge), a provider of ... the formation of its,Scientific Advisory Board (SAB) comprised ... in chronic wounds.,The Company named David Armstrong, DPM ... RN, FAAN, Joseph L. Mills, MD, PhD and ...
... Pharma, Inc., a privately-,held, specialty pharmaceutical company, announced ... A financing, which included investors Domain Associates,Latterell Venture ... is committed to the development of prescription,products based ... the unmet,needs of patients and their caregivers. Meritage ...
Other Biology Technology:Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors 2Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors 3EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 2EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 3EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board 4Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing 2
Moue Serum 8-12 Weeks Old...
Human DCIR/CLEC4A Phycoerythrin MAb (Clone 216110)...
Recombinant Mouse Wnt-3a...
One-step, microplate or cuvet, colorimetric, linear detection range 8 mg/dL to 300 mg/dL. Procedure: 5 min....
Biology Products: